These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18192507)

  • 1. Differential expression of wild-type and mutant NMMHC-IIA polypeptides in blood cells suggests cell-specific regulation mechanisms in MYH9 disorders.
    Kunishima S; Hamaguchi M; Saito H
    Blood; 2008 Mar; 111(6):3015-23. PubMed ID: 18192507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenetic mechanisms of hematological abnormalities of patients with MYH9 mutations.
    Pecci A; Canobbio I; Balduini A; Stefanini L; Cisterna B; Marseglia C; Noris P; Savoia A; Balduini CL; Torti M
    Hum Mol Genet; 2005 Nov; 14(21):3169-78. PubMed ID: 16162639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haematological characteristics of MYH9 disorders due to MYH9 R702 mutations.
    Kunishima S; Yoshinari M; Nishio H; Ida K; Miura T; Matsushita T; Hamaguchi M; Saito H
    Eur J Haematol; 2007 Mar; 78(3):220-6. PubMed ID: 17241369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [May-Hegglin anomaly: past and present--novel diagnostic test and new concept of the disease].
    Kunishima S
    Rinsho Byori; 2009 Jan; 57(1):54-9. PubMed ID: 19227191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations responsible for MYH9-related thrombocytopenia impair SDF-1-driven migration of megakaryoblastic cells.
    Pecci A; Bozzi V; Panza E; Barozzi S; Gruppi C; Seri M; Balduini CL
    Thromb Haemost; 2011 Oct; 106(4):693-704. PubMed ID: 21833445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
    Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
    Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of clinical manifestations, mutant gene and encoded protein in two Chinese MYH9-related disease families.
    Yi Y; Sen Zhang G; Xu M; San Ling Z; Ru Shao X; Zeng Li J; Ma J
    Clin Chim Acta; 2006 Nov; 373(1-2):49-54. PubMed ID: 16806139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning of the murine non-muscle myosin heavy chain IIA gene ortholog of human MYH9 responsible for May-Hegglin, Sebastian, Fechtner, and Epstein syndromes.
    D'Apolito M; Guarnieri V; Boncristiano M; Zelante L; Savoia A
    Gene; 2002 Mar; 286(2):215-22. PubMed ID: 11943476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonmuscle Myosin Heavy Chain IIA Mutation Predicts Severity and Progression of Sensorineural Hearing Loss in Patients With MYH9-Related Disease.
    Verver EJ; Topsakal V; Kunst HP; Huygen PL; Heller PG; Pujol-Moix N; Savoia A; Benazzo M; Fierro T; Grolman W; Gresele P; Pecci A
    Ear Hear; 2016; 37(1):112-20. PubMed ID: 26226608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome).
    Ghiggeri GM; Caridi G; Magrini U; Sessa A; Savoia A; Seri M; Pecci A; Romagnoli R; Gangarossa S; Noris P; Sartore S; Necchi V; Ravazzolo R; Balduini CL
    Am J Kidney Dis; 2003 Jan; 41(1):95-104. PubMed ID: 12500226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal manifestations of patients with MYH9-related disorders.
    Han KH; Lee H; Kang HG; Moon KC; Lee JH; Park YS; Ha IS; Ahn HS; Choi Y; Cheong HI
    Pediatr Nephrol; 2011 Apr; 26(4):549-55. PubMed ID: 21210153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease.
    Pecci A; Panza E; Pujol-Moix N; Klersy C; Di Bari F; Bozzi V; Gresele P; Lethagen S; Fabris F; Dufour C; Granata A; Doubek M; Pecoraro C; Koivisto PA; Heller PG; Iolascon A; Alvisi P; Schwabe D; De Candia E; Rocca B; Russo U; Ramenghi U; Noris P; Seri M; Balduini CL; Savoia A
    Hum Mutat; 2008 Mar; 29(3):409-17. PubMed ID: 18059020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A notable case report of May-Hegglin anomaly with immune complex-related nephropathy: a genetic and histological analysis.
    Ohtsuka Y; Kanaji T; Nishi M; Sakai N; Sato T; Aoki S; Wakayama K; Nakazato S; Hisano S; Sado Y; Kawachi H; Izuhara K; Hamasaki Y
    Clin Nephrol; 2011 Mar; 75(3):255-62. PubMed ID: 21329637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the first in cis mutations in MYH9 disorder.
    Miyajima Y; Kunishima S
    Eur J Haematol; 2009 Apr; 82(4):288-91. PubMed ID: 19191864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders.
    Pecci A; Noris P; Invernizzi R; Savoia A; Seri M; Ghiggeri GM; Sartore S; Gangarossa S; Bizzaro N; Balduini CL
    Br J Haematol; 2002 Apr; 117(1):164-7. PubMed ID: 11918549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies and MYH9 disorders].
    Kunishima S
    Rinsho Byori; 2009 Apr; 57(4):365-70. PubMed ID: 19489439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal injury associated with
    Yoshikawa K; Kunishima S; Kurihara H; Takahashi K; Fukuta A; Murai K; Echizenya T; Nakaya I; Soma J
    Clin Nephrol; 2023 Mar; 99(3):153-160. PubMed ID: 36602281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYH9-related platelet disorders.
    Althaus K; Greinacher A
    Semin Thromb Hemost; 2009 Mar; 35(2):189-203. PubMed ID: 19408192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYH9-Related Thrombocytopenia: Four Novel Variants Affecting the Tail Domain of the Non-Muscle Myosin Heavy Chain IIA Associated with a Mild Clinical Evolution of the Disorder.
    Zaninetti C; De Rocco D; Giangregorio T; Bozzi V; Demeter J; Leoni P; Noris P; Ryhänen S; Barozzi S; Pecci A; Savoia A
    Hamostaseologie; 2019 Feb; 39(1):87-94. PubMed ID: 29996171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with Epstein-Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease.
    Sekine T; Konno M; Sasaki S; Moritani S; Miura T; Wong WS; Nishio H; Nishiguchi T; Ohuchi MY; Tsuchiya S; Matsuyama T; Kanegane H; Ida K; Miura K; Harita Y; Hattori M; Horita S; Igarashi T; Saito H; Kunishima S
    Kidney Int; 2010 Jul; 78(2):207-14. PubMed ID: 20200500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.